Team:Northwestern/Project

From 2014.igem.org

(Difference between revisions)
Line 136: Line 136:
</header>
</header>
-
<p>The possibilities through synthetic biology are endless, but oftentimes the foundational scientific methods are not fully optimized or explored. Each project operates fairly autonomously, pulling on the work of others to aid research, yet sometimes plowing ahead to solve the problem at hand without the contributions from predecessors. The most categorized and recognized promoters are the Anderson Promoters. However, the rank classification for these promoters are based on the relative strength of maximum fluorescence and nothing else
+
<p>The cornerstone of synthetic biology is the characterization of genetic parts for predictable action in an engineered biochemical system. Currently this characterization of parts is limited to the “Model Organisms” of synthetic biology: E. coli, yeast, and C. elegans. While this work has been very successful in pioneering research in synthetic biology, characterization in a given model organism such as the primary bacterial model, E. coli, does not necessarily hold true across all bacteria. Therefore, the majority of research overlooks the possible benefits of synthetic work in other bacteria such as Streptomyces, Pseudomonas, and Nitrosomonas.
-
<p>We aim to categorize the function of a number of promoters based on absolute maximum fluorescence and the time it took to reach that point. For industrial applications a quicker response time can minimize reaction time which could lead to economic benefit. The goal of our project was to explore and compare the different transcriptional and translational rates of known model organisms such as E. coli to various non-model strains, with all processes taking place in cell free systems. Additionally, instead of testing all possible combinations of promoters, RBSs, and organisms, we tested a select number and then used predictive modeling to assess which combination yielded the strongest glow/signal/fluorescence. This is in the hopes that by compiling a list of well-characterized parts such as promoters and RBSs, the information could be used to further the field of synthetic biology through environmental, health, and industrial applications by minimizing the need to extensively modify E. Coli to meet particular environmental factors.
+
<p>The main reason for this omission is that initiating work in these organisms is very challenging due to the present difficulty in attempting to transform these non-model strains. Standard protocols have not been developed in all bacteria for incorporation of synthetic DNA through transformation due to the difficulty in developing these protocols. The development of these protocols can be very unrewarding as the investment in time is high, the success rate is often low, and the incentive is small since very few parts are characterized for non-model strains.
 +
 
 +
<p> NU Models seeks to crack open the field relating to non-model strains. We bypass transformation difficulties by utilizing a cell-free system to characterize a number of promoters and RBSs to incentivize future work in promising non-model strains. Past literature has indicated that characterization in cell-free systems in E. coli has a high correlation to characterization in living cell systems. This indicates that cell-free systems may also be a predictive model for living cells of non-model strains of bacteria.
 +
 
 +
<p> Our organisms which are non-model in the field of synthetic biology are actually model organisms in their own fields. Streptomyces species have long been a source of novel antibiotics. The impressive secondary metabolism of Streptomyces species is a unique feature to this Genus and provides potential applications impossible in E. coli. Pseudomonas has long been used in agriculture on crops to outcompete other organisms. Nitrosomonas is the model for obligate ammonia autotrophs and is used in bioremediation.
 +
 
 +
<p> The development of systems characterizing parts for these organisms is important for the development of new biotechnologies. The innate skill-set of these non-model organisms have potential to allow work that E. coli is ill-equipped to handle.
</p>
</p>

Revision as of 20:36, 15 August 2014

Our Project: Modelling Non-Model Organism

Overview

We are still working on our project description...

The cornerstone of synthetic biology is the characterization of genetic parts for predictable action in an engineered biochemical system. Currently this characterization of parts is limited to the “Model Organisms” of synthetic biology: E. coli, yeast, and C. elegans. While this work has been very successful in pioneering research in synthetic biology, characterization in a given model organism such as the primary bacterial model, E. coli, does not necessarily hold true across all bacteria. Therefore, the majority of research overlooks the possible benefits of synthetic work in other bacteria such as Streptomyces, Pseudomonas, and Nitrosomonas.

The main reason for this omission is that initiating work in these organisms is very challenging due to the present difficulty in attempting to transform these non-model strains. Standard protocols have not been developed in all bacteria for incorporation of synthetic DNA through transformation due to the difficulty in developing these protocols. The development of these protocols can be very unrewarding as the investment in time is high, the success rate is often low, and the incentive is small since very few parts are characterized for non-model strains.

NU Models seeks to crack open the field relating to non-model strains. We bypass transformation difficulties by utilizing a cell-free system to characterize a number of promoters and RBSs to incentivize future work in promising non-model strains. Past literature has indicated that characterization in cell-free systems in E. coli has a high correlation to characterization in living cell systems. This indicates that cell-free systems may also be a predictive model for living cells of non-model strains of bacteria.

Our organisms which are non-model in the field of synthetic biology are actually model organisms in their own fields. Streptomyces species have long been a source of novel antibiotics. The impressive secondary metabolism of Streptomyces species is a unique feature to this Genus and provides potential applications impossible in E. coli. Pseudomonas has long been used in agriculture on crops to outcompete other organisms. Nitrosomonas is the model for obligate ammonia autotrophs and is used in bioremediation.

The development of systems characterizing parts for these organisms is important for the development of new biotechnologies. The innate skill-set of these non-model organisms have potential to allow work that E. coli is ill-equipped to handle.